Next Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | $269K | Buy |
3,558
+299
| +9% | +$22.6K | 0.02% | 779 |
|
2021
Q3 | $365K | Buy |
3,259
+43
| +1% | +$4.82K | 0.03% | 597 |
|
2021
Q2 | $520K | Sell |
3,216
-174
| -5% | -$28.1K | 0.04% | 446 |
|
2021
Q1 | $413K | Buy |
3,390
+1,116
| +49% | +$136K | 0.04% | 495 |
|
2020
Q4 | $349K | Buy |
2,274
+571
| +34% | +$87.6K | 0.03% | 502 |
|
2020
Q3 | $143K | Buy |
+1,703
| New | +$143K | 0.02% | 732 |
|
2020
Q2 | – | Sell |
-883
| Closed | -$37K | – | 857 |
|
2020
Q1 | $37K | Buy |
883
+758
| +606% | +$31.8K | ﹤0.01% | 1080 |
|
2019
Q4 | $8K | Sell |
125
-484
| -79% | -$31K | ﹤0.01% | 1834 |
|
2019
Q3 | $25K | Buy |
609
+549
| +915% | +$22.5K | ﹤0.01% | 1347 |
|
2019
Q2 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 1995 |
|
2019
Q1 | – | Sell |
-130
| Closed | -$4K | – | 1698 |
|
2018
Q4 | $4K | Buy |
+130
| New | +$4K | ﹤0.01% | 1587 |
|